GS-9820

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-9820, covering 2016-05-17 to 2016-05-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies [Phase 1]